What’s Propelling Medidata Solutions Incorporated (NASDAQ:MDSO) After Higher Shorts Reported?

February 15, 2018 - By Winifred Garcia

 What’s Propelling Medidata Solutions Incorporated (NASDAQ:MDSO) After Higher Shorts Reported?

Investors sentiment increased to 1.23 in Q3 2017. Its up 0.06, from 1.17 in 2017Q2. It is positive, as 38 investors sold Medidata Solutions, Inc. shares while 60 reduced holdings. 33 funds opened positions while 88 raised stakes. 59.30 million shares or 4.96% more from 56.50 million shares in 2017Q2 were reported.
Deutsche Commercial Bank Ag holds 0.01% or 252,289 shares in its portfolio. Crestpoint Mngmt Ltd holds 15,500 shares. Weaver C Barksdale And Assocs holds 0% or 37 shares. United Kingdom-based Legal & General Group Pcl has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). Paloma Prns Mgmt Com holds 17,350 shares. Massachusetts-based Geode Cap Mgmt Limited Company has invested 0.01% in Medidata Solutions, Inc. (NASDAQ:MDSO). Wells Fargo & Mn accumulated 219,054 shares. Oregon Pub Employees Retirement Fund holds 20,438 shares or 0.03% of its portfolio. Tortoise Inv Mgmt Ltd Liability Corp holds 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 167 shares. Cordasco Network holds 300 shares. Moreover, Financial Bank Of Mellon Corporation has 0.02% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 800,730 shares. Rockefeller Fincl has 0.48% invested in Medidata Solutions, Inc. (NASDAQ:MDSO). Morgens Waterfall Vintiadis reported 1.01% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Delta Asset Mngmt Lc Tn holds 0% or 26 shares. Prelude Limited Company, a New York-based fund reported 2,403 shares.

Since August 15, 2017, it had 0 buys, and 3 insider sales for $474,820 activity. $372,650 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) shares were sold by Capone Michael L.

The stock of Medidata Solutions Incorporated (NASDAQ:MDSO) registered an increase of 11.09% in short interest. MDSO’s total short interest was 6.11M shares in February as published by FINRA. Its up 11.09% from 5.50 million shares, reported previously. With 555,500 shares average volume, it will take short sellers 11 days to cover their MDSO’s short positions. The short interest to Medidata Solutions Incorporated’s float is 11.44%.

The stock increased 4.75% or $3.02 during the last trading session, reaching $66.59. About 625,472 shares traded or 12.04% up from the average. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 68.37% since February 15, 2017 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $3.90 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 89.99 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. had 43 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was upgraded by Suntrust Robinson on Friday, February 10 to “Buy”. Jefferies maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating on Thursday, February 8. Jefferies has “Hold” rating and $68.0 target. The company was maintained on Thursday, February 11 by Needham. The rating was upgraded by Dougherty to “Buy” on Monday, November 13. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Hold” rating given on Thursday, September 28 by Jefferies. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Overweight” rating given on Wednesday, September 9 by KeyBanc Capital Markets. On Tuesday, September 13 the stock rating was maintained by Deutsche Bank with “Buy”. Morgan Stanley maintained Medidata Solutions, Inc. (NASDAQ:MDSO) on Thursday, July 20 with “Overweight” rating. The firm earned “Buy” rating on Wednesday, June 14 by Morgan Stanley. On Friday, October 27 the stock rating was maintained by SunTrust with “Buy”.

Another recent and important Medidata Solutions, Inc. (NASDAQ:MDSO) news was published by Seekingalpha.com which published an article titled: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q3 2017 Results – Earnings Call …” on October 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: